GeorgeIoannouMD

Professor, Medicine, University of Washington School of Medicine

Dr. Ioannou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1660 S Columbian Way
S-111-Gi, Vapshcs
Seattle, WA 98108
Phone+1 206-277-3136

Fax+1 206-764-2232

PubMed

Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation.
George N Ioannou, Kristin Berry, Nallakkandi Rajeevan, Yuli Li, Lei Yan
Annals of Internal Medicine. 2025-02-04
Severity and Long-Term Mortality of COVID-19, Influenza, and Respiratory Syncytial Virus.
Kristina L Bajema, David P Bui, Lei Yan, Yuli Li, Nallakkandi Rajeevan
JAMA Internal Medicine. 2025-01-27
A framework for monitoring RSV prevention product effectiveness in the United States.
Lauren E Roper, Ruth Link-Gelles, Diya Surie, Jennifer DeCuir, Laura D Zambrano
Vaccine. 2025-01-25

Journal Articles

Hepatitis C–related Hepatocellular Carcinoma Incidence in the Veterans Health Administration After Introduction of Direct-Acting Antivirals
Lauren A Beste, George N Ioannou, JAMA

Receipt of Alcohol-Related Care Among Patients with HCV and Unhealthy Alcohol UseMay 2018

Home Test Offers Earlier Diagnoses for Liver Disease PatientsApril 3rd, 2023
The VA Launches Largest-Ever Trial on Screening Methods for Liver CancerDecember 21st, 2022
VA Launches Largest Ever Liver Cancer Screening StudyDecember 13th, 2022
Join now to see all